Translate this page into:
Transfusion-related acute lung injury and transfusion-associated circulatory overload: Clinicoradiographic picture of common entities uncommonly reported!!
*Corresponding author: Aanchal Bhayana, Assistant Professor, Department of Radiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India. aanchalbhayana@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Bhayana A, Swarup MS, Thakur P, Kumar P, Garg D. Transfusion-related acute lung injury and transfusion-associated circulatory overload: Clinicoradiographic picture of common entities uncommonly reported!! Case Rep Clin Radiol. 2024;2:19-22. doi: 10.25259/CRCR_37_2023
Abstract
Transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO) are post-transfusion life-threatening pulmonary complications. We report a case of TRALI in a 25-year-old postpartum female. Various investigators in past have published these entities in critical care/hematology literature; however, there is a lack of awareness among reporting radiologists, due to paucity of literature in radiology journals. This report aims at discussing clinicoradiographic picture of TRALI and its close differential TACO. This would help in enhancing knowledge of these uncommonly reported entities, and preventing significant morbidity and mortality by initiating appropriate management by critical care clinicians.
Keywords
Transfusion-related acute lung injury
Transfusion-associated circulatory overload
Transfusion
Pulmonary complications
INTRODUCTION
Transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO) are life-threatening transfusion-related pulmonary complications, presenting as acute respiratory distress syndromes with often overlapping clinicoradiographic pictures. Differentiating these two can be challenging for clinicians, leading to delayed or inaccurate diagnosis. Although these complications have been extensively reported in critical care literature, there is paucity of literature on radiographic features in Radiology journals.[1-5] The purpose of this report is to discuss the clinicoradiographic features of these two entities, especially highlighting the key differentiating findings, in an attempt to guide clinicians in early diagnosis and appropriate management.
CASE REPORT
A 25-year-old female underwent emergency lower segment cesarean section due to foetal distress, transfused with 2 pints of blood, because of peripartum blood loss. After 2 h of blood transfusion, she developed acute onset dyspnea, tachypnea (Respiratory rate of 60/min), and hypoxia (SpO2-82%) for which she was admitted to the intensive care unit (ICU). Her further blood transfusions were stopped. At the time of admission, she was febrile, with normal blood pressure.
Medical history was insignificant. On clinical examination, no neck vein distension or abnormal heart sounds or murmurs was observed. Chest X-ray at the time of admission, showed diffuse interstitial and patchy alveolar air space opacities in bilateral lungs, with a prominent right horizontal fissure (likely due to fissural effusion), with no obvious cardiomegaly [Figure 1]. Bedside echocardiography was normal with good systolic and diastolic function with a normal size of cardiac chambers. Supportive care was started with oxygen administration (6L/min) on a nasal cannula. However, the patient was intubated owing to increasing respiratory distress and the inability to maintain adequate oxygen saturation. Complete blood counts revealed mild leukocytosis, varying from 15,000 to 26,000. Pro-BNP was found to be within the normal range. Serological assay for antibodies to human leukocyte antigen (HLA) and human neutrophil antigen (HNA) could not be done, due to non-availability in emergency. The patient was stable in ICU and showed clinical improvement the next day. Follow-up chest X-ray after 48 h of ICU admission revealed near complete resolution of pulmonary opacities [Figure 2]. Clinicoradiographic picture of this patient was suggestive of TRALI over TACO.
DISCUSSION
TRALI and TACO are post-transfusion reactionary pulmonary edema, seen after transfusing blood products like whole blood, fresh frozen plasma, platelets, cryoprecipitate, granulocytes, intravenous immune globulin, allogeneic/autologous stem cells, and packed red blood cells.[1,2,6,7] These are broadly defined as acute respiratory distress, new onset hypoxemia, and bilateral pulmonary infiltrates on chest X-ray occurring within 6 h of blood transfusion.[8,9] According to Food and Drug Administration report, TACO is the second most common cause of transfusion-related fatalities (10% in TACO, 65% in TRALI).[10] The National Heart, Lung, and Blood Institute working group and Canadian Consensus conference guidelines defined TRALI as “new acute lung injury (ALI) that occurs during or within 6 h after transfusion of blood products, with a clear temporal relationship, in patients with or without risk factors for ALI other than transfusion.”[3,7] TRALI was first reported in 1950, but the term was coined by Popovsky et al. in 1983.[4-8] About 5–25% of TRALI cases are reported to be fatal, with most of the patients showing full recovery within 72 h.[3,5,7]
TRALI is a permeability/non-cardiogenic pulmonary edema, while TACO is hydrostatic/cardiogenic pulmonary edema.[7] TRALI occurs due to neutrophil-mediated damage to pulmonary capillaries, leading to exudative protein-rich fluid leak into alveolar space. Two hypotheses have been proposed in the medical literature regarding the etiopathogenesis of TRALI. First is the presence of donor antibodies against HLA/HNA expressed in the recipient’s pulmonary capillaries, which cause capillary damage. The second explanation is “Two Hit Hypothesis,” wherein the patient has an underlying inflammatory condition like sepsis or recent surgery which acts as the primary stimulus, causing neutrophil sequestration in pulmonary capillaries.
The transfused blood products containing antibodies and bioactive lipids activate these sequestered neutrophils to release proteases, damaging the capillary endothelium.[3-5,7,9] TACO results from acute congestive heart failure with increased central venous pressure and pulmonary blood volume leading to increased hydrostatic pressure and fluid extravasation into alveolar space.[1,2,6,7]
The clinical presentation of TRALI includes fever, hypotension, tachycardia, dyspnea, and sometimes a transient decrease in neutrophil count, with a need for mechanical ventilation.[1,2,6-9] Chest X-ray shows pulmonary edema, with interstitial and pulmonary alveolar opacities, and septal lines, with or without pleural effusions.[1,2,6,7,9] These lung opacities usually clear within 96 h in 80% of patients.[1] Conversely, TACO presents with dyspnea, tachypnea, jugular venous distension, elevated systolic blood pressure, and S3 on auscultation.[1,2,6-9] Patients younger than 3 years or older than 60 years are generally at higher risk of TACO, due to higher probability of underlying occult cardiac dysfunction, which manifests after blood transfusion as acute congestive heart failure.[5,7] An important biomarker, B-type natriuretic peptide (BNP) may help in differentiating TACO from TRALI, as cardiogenic pulmonary edema in TACO results in myocardial stretching leading to increased post-transfusion BNP values.[5,7] The key differentiating features between TRALI and TACO are enumerated in Table 1.
Clinico-radiographic features | TRALI | TACO |
---|---|---|
Pulmonary edema type | Exudative | Transudative |
Body temperature | Usually increased | No change |
Blood pressure | Hypotension | Hypertension |
Neck veins | No change | May be distended |
Auscultation | Rales present | Rales±S3 |
Chest X-ray | Bilateral diffuse interstitial and alveolar infiltrates | Bilateral diffuse interstitial and alveolar infiltrates, ±cardiomegaly±pleural effusion |
Echocardiography (ECHO) | Usually normal, with normal or decreased Ejection fraction | Systolic dysfunction may be present, with usually increased ejection fraction |
Fluid balance | Normal or negative | Positive |
Response to diuretic | Not significant | Significant change |
White blood cell count | Increased or Transient decrease in counts | Unchanged |
Brain natriuretic peptide (BNP) and n-terminal pro-brain natriuretic peptide (NT-pro BNP) |
Normal or low | Usually Increased |
Leukocyte antibodies | Donor leukocyte antibodies present, cross match incompatibility between donor and recipient | Usually not seen |
The management mainly involves immediate discontinuation of further transfusion of blood products.[1-10] In clinicoradiographically suspected cases of TRALI, treatment includes supplemental oxygen, and careful fluid administration, with the requirement of ventilatory and pharmacologic pressure support in severe cases.[1,2,6,7] While in clinicoradiographically suspected cases of TACO, treatment includes supplemental oxygen, diuretics for fluid overload, and mechanical ventilation if needed. The incidence of TACO can be reduced by recipient screening for undiagnosed cardiac insufficiency and by decreasing the rate and volume of transfusions.[1,2,6-9] Conversely, the incidence of TRALI can be reduced by screening the donors for HLA/HNA antibodies, refusing donors with a previous history of transfusion reaction, and using male-only donors.[2,6,7]
CONCLUSION
TRALI and TACO are post-transfusion acute respiratory distress pulmonary edema carrying high morbidity and mortality. A better understanding of these entities by radiologists would help in dispensing an early and accurate report, aiding in differentiating cardiogenic from noncardiogenic edema, thereby guiding the clinicians in ordering appropriate investigations, planning further management, and lowering the associated mortality.
TEACHING POINTS
Transfusion-related acute lung injury (TRALI) and Transfusion-associated circulatory overload (TACO) are life-threatening transfusion-related pulmonary complications, presenting as acute respiratory distress syndromes.
TRALI is a permeability/non-cardiogenic pulmonary edema, while TACO is hydrostatic/cardiogenic pulmonary edema.
MCQs
-
TRALI stands for?
Transfusion-related acute lung injury
Transfusion-related acute lung infection
Transfusion-related acute lung inflammation
Transfusion-related acute lung illness
Answer Key: a
-
TACO stands for?
Transfusion-associated cardiac overactivity
Transfusion-associated cardiac overload
Transfusion-associated coronary occlusion
Transfusion-associated circulatory overload
Answer Key: d
-
Which of the following statement regarding post transfusion pulmonary complications is incorrect?
TRALI occurs due to exudative pulmonary edema
TACO occurs due to hydrostatic pulmonary edema
Donor leukocyte antibodies are present in TACO
Cardiomegaly with pleural effusion is commonly observed in TACO
Answer Key: c
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Conflicts of interest
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
Financial support and sponsorship
Nil.
References
- TACO and TRALI: Visualising transfusion lung injury on plain film. BMJ Case Rep. 2020;13:e230426.
- [CrossRef] [PubMed] [Google Scholar]
- Radiographic manifestations of transfusion-related acute lung injury. Clin Imaging. 2013;37:1020-3.
- [CrossRef] [PubMed] [Google Scholar]
- Distinguishing between transfusion related acute lung injury and transfusion associated circulatory overload. Curr Opin Hematol. 2007;14:682-7.
- [CrossRef] [PubMed] [Google Scholar]
- Transfusion-associated circulatory overload and transfusion-related acute lung injury. Blood. 2019;133:1840-53.
- [CrossRef] [PubMed] [Google Scholar]
- A suspected case of transfusion related acute lung injury. Lung India. 2011;28:216-8.
- [CrossRef] [PubMed] [Google Scholar]
- Transfusion-related acute lung injury. Blood. 2005;105:2266-73.
- [CrossRef] [PubMed] [Google Scholar]
- Fatalities reported to food and drug administration (FDA) following blood collection and transfusion. Annual Summary for Fiscal Year 2017.
- [Google Scholar]
- Transfusion-related acute lung injury: Definition and review. Crit Care Med. 2005;33:721-6.
- [CrossRef] [PubMed] [Google Scholar]
- Transfusion-related acute lung injury: An update. Hematol Am Soc Hematol Educ Program. 2006;1:497-501.
- [CrossRef] [PubMed] [Google Scholar]
- How clinicians can minimize transfusion-related adverse events? Transfus Clin Biol. 2018;25:257-61.
- [CrossRef] [PubMed] [Google Scholar]